Poster
Vol. 39 No. 2 (2024)
https://doi.org/10.4081/mm.2024.13220

The burden of Candida parapsilosis bloodstream infections: from azole resistance to biofilm production

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 9 October 2024
Published: 3 December 2024
251
Views
159
Downloads

Authors

N. Ferraro
nicola.ferraro01@universitadipavia.it
Specialization School of Microbiology and Virology, Università degli Studi di Pavia, Pavia, Italy.
E. N. R. Iskandar
Specialization School of Microbiology and Virology, Università degli Studi di Pavia, Pavia, Italy.
G. Ferrari
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
A. M. G. Pitrolo
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
A. Prigitano
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
M. C. Esposto
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
F. Baldanti
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia; Clinical, Surgical, Diagnostic and Pediatric Sciences Department, Università degli Studi di Pavia, Pavia, Italy.
C. Cavanna
Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Not available.

Downloads

Download data is not yet available.

How to Cite



The burden of Candida parapsilosis bloodstream infections: from azole resistance to biofilm production. (2024). Microbiologia Medica, 39(2). https://doi.org/10.4081/mm.2024.13220
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.